FDA Sets Child Safety Rule After Death In Amgen Trial
The U.S. Food and Drug Administration on Tuesday published a final rule strengthening safeguards for children enrolled in clinical trials on the same day it suspended pediatric trials of Amgen Inc.'s...To view the full article, register now.
Already a subscriber? Click here to view full article